Athira pharma to host educational webinar on the clinical applications of erp p300

Bothell, wash., oct. 29, 2021 (globe newswire) -- athira pharma, inc. (nasdaq: atha), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and stop neurodegeneration, today announced it will host an educational webinar to review event-related potential (erp) p300 latency as a functional measure of working memory processing speed, and its correlation to cognition. the webinar will be webcast live on friday, nov. 5, at 9 a.m. pt / 12 p.m. et, and will feature presentations by:
ATHA Ratings Summary
ATHA Quant Ranking